Glanbia PLC (GL9) Cash Flow Statement

A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.

Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, capsules, tablets, ready-to-eat bars, and ready-to-drink beverage.

Total Cash From Operating Activities Chart for Glanbia PLC

Glanbia PLC (GL9) operating cash flow for FY2025 was EUR 368.5M, a -16.9% change from FY2024. Glanbia PLC's operating cash flow grew from EUR 17.6M in 1991 to EUR 368.5M in 2025 (1988.5% over 34 years). Operating cash flow compound annual growth rate: 5-year CAGR of 5.8%, 10-year CAGR of 2.9%, 20-year CAGR of 5.1%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Cash From Operating Activities (Euros)

R&D as % of Revenue

Key Stats

Market Cap
€5.38B
Implied Share Price
€22.24
Enterprise Value
€6.14B
Revenue (TTM)
€4.10B
EBITDA
€486.40M
Profit Margin
5.80%
Trailing P/E
26.48
Forward P/E
15.34
Price/Book (MRQ)
3.31
Price/Sales (TTM)
1.31
EV/EBITDA
15.89
EV/Revenue
1.74
Dividend Yield
2.41%
Book Value
€6.73
Free Cash Flow (FY2025)
€283.70M
Free Cash Flow Yield
5.28%

Snapshot as of 4th September 2026 — not point-in-time controlled, may lag the live market by a few days.